Centre for Diagnosis of Inherited Alpha-1 Antitrypsin Deficiency, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Centre for Diagnosis of Inherited Alpha-1 Antitrypsin Deficiency, Laboratory of Biochemistry and Genetics, Pulmonology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Int J Mol Sci. 2022 Aug 30;23(17):9859. doi: 10.3390/ijms23179859.
Alpha1-antitrypsin (AAT) is a serine protease inhibitor that is encoded by the highly polymorphic gene. Mutations in this gene can lead to AAT deficiency (AATD), which is associated with an increased risk of lung and/or liver disease. On the basis of electrophoretic migration, AAT variants are named with capital letters; M (medium) signifies the normal protein. Among pathological variants, the M-like ones represent a heterogeneous group of rare allelic variants that exhibit the same electrophoretic pattern as the M wild-type protein, which makes them difficult to detect with routine methods. In order to avoid their misdiagnosis, the present study defines and validates effective methods for the detection of two pathogenic M-like variants, M and M. Comparison of protein phenotypes using isoelectric focusing of samples that presented the M variant, as revealed by exons 5 sequencing, identified a particular electrophoretic pattern amenable to the M protein. The specific phenotyping pattern was retrospectively validated, thus enabling the detection of 16 patients with M variant among the subjects already tested but not sequenced according to our diagnostic algorithm. The M allele was detected by intron 4 sequencing of SERPINA1 gene. M and M are often misdiagnosed and the introduction of diagnostic improvements can help the clinical management, especially in patients with established lung disease without any other reported risk factors.
α1-抗胰蛋白酶(AAT)是一种丝氨酸蛋白酶抑制剂,由高度多态性的基因编码。该基因的突变可导致 AAT 缺乏症(AATD),从而增加患肺病和/或肝病的风险。根据电泳迁移率,AAT 变体以大写字母命名;M(中等)表示正常蛋白。在病理性变体中,M 样变体代表一组罕见的等位基因变体,它们表现出与 M 野生型蛋白相同的电泳模式,这使得它们难以用常规方法检测。为了避免误诊,本研究定义并验证了检测两种致病性 M 样变体 M 和 M 的有效方法。使用样本的等电聚焦比较使用外显子 5 测序显示的 M 变体的蛋白表型,确定了一种适用于 M 蛋白的特殊电泳模式。对已经测试但未根据我们的诊断算法进行测序的对象进行回顾性验证,从而验证了特定的表型模式。由此,在已经接受测试但未按我们的诊断算法进行测序的对象中,检测到了 16 例 M 变体患者。M 等位基因通过 SERPINA1 基因的内含子 4 测序检测到。M 和 M 经常被误诊,引入诊断改进可以帮助临床管理,特别是在没有任何其他报告风险因素的已确诊肺病患者中。